ZATTARIN, EMMA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 124
AS - Asia 69
EU - Europa 28
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 2
Totale 233
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 117
SG - Singapore 34
IT - Italia 18
CN - Cina 13
VN - Vietnam 8
HK - Hong Kong 6
CA - Canada 3
FI - Finlandia 3
KR - Corea 3
MX - Messico 3
BD - Bangladesh 2
FR - Francia 2
AR - Argentina 1
BR - Brasile 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CL - Cile 1
DE - Germania 1
GB - Regno Unito 1
ID - Indonesia 1
IN - India 1
MK - Macedonia 1
SA - Arabia Saudita 1
SC - Seychelles 1
SI - Slovenia 1
UA - Ucraina 1
UY - Uruguay 1
VE - Venezuela 1
Totale 228
Salva come PNG Salva come JPEG
Città #
San Jose 22
Singapore 21
Ashburn 13
Council Bluffs 11
Beijing 6
Hong Kong 6
Los Angeles 6
Ho Chi Minh City 5
Modena 5
Santa Clara 4
Dallas 3
Lappeenranta 3
New York 3
Seoul 3
Boardman 2
Concord 2
Denver 2
Ocala 2
Savannah 2
Toronto 2
Abidjan 1
Brooklyn 1
Cagliari 1
Chicago 1
Cleveland 1
Correggio 1
Dubuque 1
Frankfurt am Main 1
Genoa 1
Gia Nghĩa 1
Hanoi 1
Heber 1
Jakarta 1
Jamestown 1
Jeddah 1
Kyiv 1
La Plata 1
Las Vegas 1
Lauterbourg 1
Ljubljana 1
Marseille 1
Martinsburg 1
Mesa 1
Mexico City 1
Milan 1
Montevideo 1
Naples 1
Nassau 1
Orta Nova 1
Peterborough 1
Phoenix 1
Pompano Beach 1
Rancagua 1
Rome 1
Rubio 1
Sacramento 1
Salem 1
Skopje 1
Tampa 1
The Bronx 1
Tlajomulco de Zúñiga 1
Tláhuac 1
Vũng Tàu 1
Xanxerê 1
Totale 167
Salva come PNG Salva come JPEG
Nome #
Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019 69
Impact of Ethnicity on Breast Cancer Outcome: A Systematic Review and Meta-Analysis of Randomized Phase III Trials of the Last Decade. 60
Impaired glucose tolerance in women with BRCA1 versus BRCA2 pathogenic or likely pathogenic variants: Results from a prospective cohort study 59
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer 45
Totale 233
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.302
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.302
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026134 0 0 0 0 0 15 20 19 30 22 19 9
2026/202799 24 39 36 0 0 0 0 0 0 0 0 0
Totale 233